Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enara Health vs Spry

Enara Health
Graded #221

Higher grade

vs+8.5
Spry
Graded #408

Lower grade

The verdict

Enara Health takes it — 65.3/100 to 56.8/100.

Enara Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +9
45
54
Dose & formulationSpry +11
53
64
Clinical oversightEnara Health +37
92
55
Labs & monitoringEnara Health +33
85
52
FulfillmentEnara Health +5
66
61
Contract termsEven
55
55
Enara Health · left barSpry · right bar

The numbers

MetricEnara HealthSpry
WeighScore65.3/10056.8/100
GradeCC
Scorecard rank#221#408
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, compounded)
Coverage6 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Enara Health

Graded #221 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) not compounded
  • Insurance-based with prior-auth coverage for over 65% of members
  • Board-certified obesity-medicine physicians
  • Comprehensive program: dietitian, coaching, metabolic and genetic testing
  • Established since 2015 with clinical track record

Where it loses points

  • Available in only six states via partner clinics
  • Requires in-network insurance; not a flat cash-pay option
  • Not a pure-telehealth nationwide service
  • Out-of-pocket cost varies by insurance coverage
  • No compounded budget alternative for the uninsured
Spry

Graded #408 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard